Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.
2.

Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.

Schlienger RG, Fischer LM, Jick H, Meier CR.

Drug Saf. 2004;27(14):1157-65.

PMID:
15554748
3.

Antidepressants and the risk of suicidal behaviors.

Jick H, Kaye JA, Jick SS.

JAMA. 2004 Jul 21;292(3):338-43.

PMID:
15265848
4.

Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study.

Monster TB, Johnsen SP, Olsen ML, McLaughlin JK, Sørensen HT.

Am J Med. 2004 Nov 15;117(10):732-7.

PMID:
15541322
5.

Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage.

Renoux C, Vahey S, Dell'Aniello S, Boivin JF.

JAMA Neurol. 2017 Feb 1;74(2):173-180. doi: 10.1001/jamaneurol.2016.4529.

PMID:
27918771
6.

Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.

Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A.

Am J Epidemiol. 2003 Jul 1;158(1):77-84.

PMID:
12835289
7.

Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?

Tata LJ, Fortun PJ, Hubbard RB, Smeeth L, Hawkey CJ, Smith CJ, Whitaker HJ, Farrington CP, Card TR, West J.

Aliment Pharmacol Ther. 2005 Aug 1;22(3):175-81.

8.
9.

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.

Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, Evans S, Gunnell D.

BMJ. 2005 Feb 19;330(7488):389.

10.

Does the use of SSRIs reduce medical care utilization and expenditures?

Chung S.

J Ment Health Policy Econ. 2005 Sep;8(3):119-29.

PMID:
16278500
11.

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction.

Sauer WH, Berlin JA, Kimmel SE.

Circulation. 2003 Jul 8;108(1):32-6. Epub 2003 Jun 23.

12.

Trends in the prescribing of antidepressants following acute myocardial infarction, 1993-2002.

Benazon NR, Mamdani MM, Coyne JC.

Psychosom Med. 2005 Nov-Dec;67(6):916-20.

PMID:
16314596
13.

Antidepressant use and risk of adverse outcomes in older people: population based cohort study.

Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J.

BMJ. 2011 Aug 2;343:d4551. doi: 10.1136/bmj.d4551.

14.

A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.

Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, Chatwin J, Goddard J, Thornett A, Smith H, Campbell M, Thompson C.

Health Technol Assess. 2005 May;9(16):1-134, iii.

15.

Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.

Ziere G, Dieleman JP, van der Cammen TJ, Hofman A, Pols HA, Stricker BH.

J Clin Psychopharmacol. 2008 Aug;28(4):411-7. doi: 10.1097/JCP.0b013e31817e0ecb.

PMID:
18626268
16.

Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?

Palmsten K, Setoguchi S, Margulis AV, Patrick AR, Hernández-Díaz S.

Am J Epidemiol. 2012 May 15;175(10):988-97. doi: 10.1093/aje/kwr394. Epub 2012 Mar 22.

17.

Anti-depressant therapy and cancer risk: a nested case-control study.

Boursi B, Lurie I, Mamtani R, Haynes K, Yang YX.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1147-57. doi: 10.1016/j.euroneuro.2015.04.010. Epub 2015 Apr 17.

PMID:
25934397
19.

Serotonin-norepinephrine reuptake inhibitor antidepressants and the risk of falls in older people: case-control and case-series analysis of a large UK primary care database.

Gribbin J, Hubbard R, Gladman J, Smith C, Lewis S.

Drugs Aging. 2011 Nov 1;28(11):895-902. doi: 10.2165/11592860-000000000-00000.

PMID:
22054230
20.

The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study.

Douglas I, Smeeth L, Irvine D.

Br J Clin Pharmacol. 2011 Jan;71(1):116-20. doi: 10.1111/j.1365-2125.2010.03797.x.

Supplemental Content

Support Center